nal-IRI plus 5-FU/LV (n = 51) | |
---|---|
Median duration of treatment, months (range) | 1.9 (0.5–7.0) |
Median cycles of treatment, n (range) | 4 (2–12) |
Median relative dose intensity, n (range) | 0.87 (0.54–1.00) |
RDI ≥ 85%, n (%) | 36 (70.6) |
RDI < 85%, n (%) | 15 (29.4) |
Dose reduction in first 3 cycles, n (%) | 30 (58.8) |
Dose delay in first 3 cycles, n (%) | 13 (25.5) |